Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvia Juliana Trujillo-Cáceres has a total of 104 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    GDMT Intensity at Hospital Discharge and Associated Clinical Outcomes in Heart Failure: A Systematic Review and Network Meta-Analysis

    by Sergio Alejandro Gómez-Ochoa, Lyda Z. Rojas, Carlos A. Corona-Arias, Lizeth N. Quiroga-Pico, Laura V. Arciniegas-Landínez, Angie Yarlady Serrano-García, Angie C. Mendoza-Quiñonez, Katherin A. Gamboa, Alexandra Contreras, Juliana Alexandra Hernández Vargas, et al.

    Background/Objectives: Contemporary heart failure (HF) guidelines recommend early initiation of four foundational drug classes in HFrEF. However, real-world prescription rates of guideline-directed medical therapy (GDMT) at discharge remain low, and comparative data in this setting is limited. We aimed to explore the association between GDMT intensity prescribed at or before hospital discharge and clinical outcomes. Methods: MEDLINE and EMBASE were searched through March 2026 (PROSPERO CRD420261352137). A frequentist random-effects network meta-analysis grouped regimens into four intensity nodes (single/none, double, triple, quadruple), with the primary analysis restricted to adjusted hazard ratios. The primary outcome was the composite of all-cause mortality (ACM) and HF hospitalization (HFH). Secondary outcomes were HFH alone, ACM, and cardiovascular mortality. Confidence was rated with CINeMA. Estimates are reported as associations, not treatment effects. Results: Twenty-seven studies (26 observational, 1 RCT; 73,174 patients) were included. Among SGLT2i-era cohorts, quadruple therapy was suboptimally prescribed (pooled 34%, range 11.6–55.2%). For the primary composite endpoint, more complete regimens were associated with progressively lower event rates versus single or no therapy (double: hazard ratio 0.76, 95% CI 0.68–0.84; triple: 0.72, 0.64–0.81; quadruple: 0.52, 0.36–0.75; τ2 = 0). A consistent ordinal gradient was seen across outcomes, with quadruple therapy ranking first numerically for every outcome in which it was estimable. The direction and ordering were preserved in a sensitivity analysis additionally incorporating risk ratios, on stratification by follow-up duration, and in an alternative network anchored to incomplete therapy. Because most evidence was observational, the magnitude of these associations should not be interpreted as a causal treatment effect and likely reflects residual confounding and selection bias. Conclusions: Discharge GDMT remains an important opportunity to improve outcomes in patients with HF. Adequately powered randomized trials are required to establish the incremental benefit of this approach and to close the gap between evidence and practice.


  • Top Cited Papers
    Open Access

    Healthy living concepts and definitions: A systematic review with concept analysis proposing a four-dimensional model

    by Silvia Juliana Trujillo-Cáceres, Zayne M. Roa-Díaz, Catalina Paz Figueroa, Juliana Alexandra Hernández Vargas, Lyda Z. Rojas, Andrea M. Aceros Lora, Hamidreza Raeisi-Dehkordi, Sara Beigrezaei, Vicente Artola Arita, W.M. Monique Verschuren, et al.


  • Open Access

    Adiposity in Adults and Life Expectancy with and without Cardiovascular Disease. The Doetinchem Cohort Study

    by Trujillo- Cáceres, Silvia Juliana, Annelot P. Smit, Vicente Artola Arita, Marilyne Menassa, H. Susan J. Picavet, Klodian Dhana, Oscar H. Franco, W. M. Monique Verschuren

    Background: While life expectancy (LE) in the Netherlands has increased over recent decades, it is not always accompanied by good health, particularly among individuals with adiposity. As adiposity is a major risk factor for cardiovascular disease (CVD), previous studies have explored its association with LE and CVD burden, but findings remain heterogeneous. Objective: To assess the association between adiposity and LE in adults, with and without CVD. Methods: We used data from the longitudinal Doetinchem Cohort Study (DCS), including 2,323 participants aged 50–70 years (49% women). Adiposity categories were determined (low, increased, high and very high) based on the combination of body mass index (BMI) and waist circumference (WC) thresholds for overweight and obesity based on the AACE/ACE definitions. CVD and mortality were assessed via linkage to hospital and death registries. A multistate life table approach estimated total and CVD-specific LE using transition rates between three health states—CVD-free to CVD, CVD-free to death, and CVD to death—incorporating prevalences and adjusted hazard ratios (HRs) for adiposity categories by sex and CVD status. Results: LE did not differ between adiposity categories at age 50 in both men and women. Men with very high adiposity had a 2.6-year lower LE free of CVD compared to men in the low adiposity category (difference: –2.6 years, 95% CI: –3.6, –1.5), and lived more years with CVD (difference: 2 years, 95% CI: 0.9, 2.9). Men in any adiposity category lived more years with CVD than women in a similar category. In women, there were no differences in CVD-specific LE between the adiposity categories. Conclusion: Men in the very high adiposity category lived more years with CVD compared to those in the low category. These findings highlight the need for targeted cardiovascular prevention in men with very high adiposity to delay CVD onset and promote a healthy lifespan.

  • Open Access

    Clinical and Epidemiological Characteristics of Patients with Elderly-Onset Rheumatoid Arthritis in Colombia

    by Diana Carolina Gámez-Fragozo, Silvia Juliana Trujillo-Cáceres, Diego Andrés Chavarro-Carvajal, Ana María Valbuena-Garcia, Lizbeth Acuña-Merchán, Daniel G. Fernández-Ávila

    Objective: This study aims to investigate the prevalence of elderly-onset rheumatoid arthritis (EORA) in Colombia, analyzing demographics, clinical manifestations, laboratory results, and therapeutics characteristics of EORA patients. Furthermore, it compares these with findings observed in patients affected by young-onset rheumatoid arthritis (YORA). Methods: A secondary analysis was conducted using records of all adults diagnosed with rheumatoid arthritis (RA) between 2015 and 2020 reported from 2015-2020 to the High-Cost Account, a division of the Colombian Ministry of Health and Social Protection. Comparative analyses were performed on incident cases to highlight differences between EORA and YORA patients. Results: 195.292 cases were included for prevalence analysis, with 24.933 incident cases for comparative purposes. In 2020, the prevalence of EORA in Colombia increased to 0.12%. Compared to YORA, EORA was more frequently observed in males (p p p = 0.438). At diagnosis, EORA patients were more likely to test negative for anti-CCP (p p p = 0,005). Moreover, the use of antirheumatic drugs was less frequent among EORA patients. Conclusion: Compared to YORA, EORA patients experience delayed time to diagnosis, less frequent presence of positive auto-antibodies, acute-phase reactants, and reduced use of biological therapy. These findings suggest that EORA may have a less aggressive disease course than YORA.

  • Top Cited Papers
    Open Access

    Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials

    by Vicente Artola Arita, Manuel Castro Cabezas, Juliana Alexandra Hernández Vargas, Silvia Juliana Trujillo-Cáceres, Nathalie Mendez Pernicone, Lara Anne Bridge, Hamidreza Raeisi-Dehkordi, Carmen A. W. Dietvorst, Ruben Dekker, Julieth Pilar Uriza-Pinzón, et al.

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of liver-related morbidity and mortality. Lifestyle interventions like the Mediterranean diet (MD) and exercise are recommended for management, but the most effective lifestyle approach remains unclear. A comprehensive literature search was conducted in Embase, MEDLINE via Ovid, Cochrane Central, and Web of Science Core Collection from inception to April 1, 2025, without language restrictions. We included randomized controlled trials (RCTs) in adults with MASLD or metabolic dysfunction-associated steatohepatitis (MASH) assessing the MD and/or exercise interventions on anthropometric measures, liver enzymes, and indices or grades of liver steatosis and fibrosis. The mean difference and corresponding 95% confidence interval (CI) were pooled using a random-effects model. Risk of bias was assessed with ROB-2, and evidence certainty was evaluated using GRADE. From a total of 4806 search results, 37 unique RCTs met the inclusion criteria, from which 11 assessed the MD and 27 exercise, either aerobic, resistance, or in combination, and two RCTs assessed the effect of the MD and exercise combination. Meta-analyses showed that the MD in comparison with the control significantly reduced body weight [weighted mean difference (WMD = − 2.38 kg, 95% CI − 4.11 to − 0.66), body mass index (WMD = − 0.70 kg/m2, 95% CI = − 1.03 to − 0.36), waist circumference (WC) (WMD = − 1.56 cm, 95% CI − 3.02 to − 0.09), and alanine aminotransferase (ALT) (WMD = − 3.96 IU/L, 95% CI − 6.54 to − 1.38). Aerobic and combined aerobic-resistance exercises in comparison with the control group reduced body weight (WMD = − 1.56 kg, 95%CI − 2.31 to − 0.82; WMD = − 1.90 kg, 95%CI − 3.59 to − 0.22, respectively). In addition, aerobic exercise significantly decreased WC (WMD = − 2.14 IU/L, 95%CI − 2.87 to − 1.41) and resistance exercise reduced ALT (WMD = − 15.40 IU/L, 95%CI − 28.60 to − 2.20) in patients with MASLD/MASH compared to the control group. The MD and aerobic exercise, whether alone or combined with resistance training, support weight loss and improve liver health in patients with MASLD/MASH. Standardized methods for measuring and reporting outcomes are essential to build robust evidence on the impact of lifestyle changes on clinical outcomes. PROSPERO registration code. CRD42024577846.


  • Open Access

    Independent predictors of quality of life in patients with chronic heart failure

    by Lyda Z Rojas, Laura M Cabeza, Adriana M Jurado, Luis E Echeverría, Juliana Alexandra Hernández-Vargas, Silvia Juliana Trujillo-Cáceres

    Introduction: Objective measurement of Health-Related Quality of Life (HRQoL) has proven useful in evaluating the effectiveness of medical management and its potential as a predictor of mortality and rehospitalization in patients with heart failure (HF). The aim of this study is to characterize HRQoL and determine its independent predictors in patients with chronic HF from a heart failure and transplant clinic in Colombia. Methods: This was an analytical cross-sectional study. The outcome variable was HRQoL measured using The Minnesota Living with Heart Failure Questionnaire (MLHFQ). Descriptive analysis of sociodemographic and clinical characteristics was conducted. Simple and multiple linear regressions were performed to establish predictors, considering statistical significance at p < 0.05. Results: A total of 200 patients were analyzed. 20% had Chagasic etiology. The median left ventricular ejection fraction (LVEF) was 30% (range 10 - 68%). The mean HRQoL score was 38.71 points (SD ± 22.67 points). "Multivariate analysis identified seven independent predictors of worse HRQoL: age (β=0.17), low vs. high socioeconomic status (β=13.45), HF etiology, Chagas vs. others (β=12.97), number of hospitalizations in the last year (β=2.94), Charlson index (β=3.47), digitalis use (β=7.34), and NYHA functional class III-IV vs. I-II (β=28.04). Angiotensin-converting enzyme use was associated with better HRQoL (β=-4.80). Conclusion: This study shows that HRQoL in chronic HF is significantly determined by a set of socioeconomic, clinical, and management factors. The identification of these predictors underpins the need for comprehensive and personalized care strategies to improve the quality of life of these patients

  • Open Access

    Quality of care in Colombian women with early-onset breast cancer in two time periods: findings from a nationwide administrative registry cohort

    by Ana Maria Valbuena-Garcia, Silvia Juliana Trujillo-Cáceres, Juliana Alexandra Hernández Vargas, Sandra Diaz, Lizbeth Acuña, Sandra Perdomo, Marion Piñeros


  • Open Access

    Two cosmoses, one universe: a narrative review exploring the gut microbiome's role in the effect of urban risk factors on vascular ageing

    by Lara Anne Bridge, Juliana Alexandra Hernández Vargas, Silvia Juliana Trujillo-Cáceres, Sara Beigrezaei, Angeline Chatelan, Amin Salehi-Abargouei, Taulant Muka, Julieth Pilar Uriza-Pinzón, Hamidreza Raeisi-Dehkordi, Oscar H. Franco, et al.


  • Open Access

    Smoking threats beyond being a smoker: a burden on children and adolescents’ healthy living

    by Vicente Artola Arita, Silvia Juliana Trujillo-Cáceres, Marilyne Menassa

    Vicente Artola Arita, Silvia Juliana Trujillo-Cáceres, Marilyne Menassa; Smoking threats beyond being a smoker: a burden on children and adolescents’ healthy li

  • Open Access

    Tuberculosis and immigration: the challenges in the Latin American and Colombian context

    by Darío Sebastián López, José Fernando Valderrama Vergara, Julián Alfredo Fernández-Niño, Silvia Juliana Trujillo-Cáceres